|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 165.5 SEK | +0.49% |
|
+4.42% | +23.78% |
| Apr. 25 | Transcript : Biotage AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
| Apr. 25 | Biotage AB Approves a Dividend, Payable on May 3, 2024 | CI |
Biotage AB (publ) appoints Andrew Kellett as its Interim CFO. Andrew is currently CFO of Astrea Bioseparations. He will take the Biotage CFO role as of 25 September 2023.
As previously announced, Maja Nilsson has decided to leave the position as CFO at Biotage for new challenges. Recruitment of a permanent successor as CFO continues.
| 1st Jan change | Capi. | |
|---|---|---|
| +23.78% | 1.21B | |
| -12.91% | 19.08B | |
| -46.21% | 2.65B | |
| +18.15% | 1.87B | |
| -3.12% | 1.61B | |
| -10.69% | 1.02B | |
| -20.89% | 905M | |
| -18.10% | 682M | |
| -7.14% | 716M | |
| -.--% | 301M |
BIOTAGE AB 
